Multiple myeloma is a cancer of plasma cells – a type of white blood cell found in the bone marrow. These cells normally produce antibodies to help fight infections, but in myeloma, they grow uncontrollably, crowding out healthy cells and producing abnormal proteins that can damage bones, kidneys and other organs.
Over the past decade, treatment advances, particularly in cellular therapies, have led to higher response rates and longer survival for patients.
For more resources, visit marybird.org/resources.
However, early detection is key to improving treatment outcomes. Blood and urine tests, along with biopsies and imaging tests, are used to detect and monitor multiple myeloma in patients with symptoms or risk factors.
MOST COMMON WARNING SIGNS:
OTHER SYMPTOMS INCLUDE:
Mary Bird Perkins Cancer Center offers leading-edge therapies for multiple myeloma through our Myeloma, Lymphoma and Cellular Therapy Program, led by Andrew Dalovisio, M.D.
These therapies have proven highly effective, provide long-lasting remission for previously difficult-to-treat cancers, and in some cases, a potential cure.
Mary Bird Perkins delivers these therapies in an outpatient setting, allowing patients to rest at home surrounded by loved ones instead of staying in the hospital.
Clinical trials are research studies that involve human beings in order to test new ways to prevent, detect, diagnose or treat diseases. A drug must be part of a clinical trial before the FDA will approve it to be put on the market. Oncology clinical trials are conducted in order to test new drugs or a new combination of drug treatments, new surgery and radiation therapies and new medical devices.
Every cancer center patient is evaluated for participation in a clinical trial. Those who meet the criteria to participate in clinical research receive a standard of care treatment, but with the added benefit of a trial that may enhance their outcomes.
If interested in volunteering to participate in a clinical research trial, or if you have concerns about the conduct of clinical research, please contact the Clinical Research office at (225) 215-1353, or by email at clinicalresearch@marybird.com.
